AORT

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Artivion Inc

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide.
CEO
James Mackin
Employees
1200
Headquarters

1655 Roberts Blvd NW
Kennesaw, Georgia 30144-3632
Phone: 17704193355
www.cryolife.com

News

Artivion executive sells over $61k in company stock
Aug 16, 2024 15:43pm

https://www.investing.com/news/company-news/artivion-executive-sells-over-61k-in-company-stock-93CH-3575933


Source:Investing.com
Insider Sale: Director Anthony Semedo Sells 9,709 Shares of Artivion Inc (AORT)
Aug 15, 2024 17:02pm

Insider Sale: Director Anthony Semedo Sells 9,709 Shares of Artivion Inc (AORT)


Source:GuruFocus
Earnings call: Artivion sees robust growth in Q2 2024, raises guidance
Aug 12, 2024 12:14pm

https://www.investing.com/news/stock-market-news/earnings-call-artivion-sees-robust-growth-in-q2-2024-raises-guidance-93CH-3566403


Source:Investing.com
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results
Jul 25, 2024 20:10pm

ATLANTA, July 25, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2024 financial results will be released on Thursday, August 8, 2024 after the market closes. On that day, the…


Source:PR Newswire
3 Earnings All-Stars With More Room to Run
Jul 03, 2024 12:00pm

Earnings are essential to determining which stocks will outperform. Unsurprisingly, earnings outperformers also see strong price appreciation . Even if a stock’s share price has increased significantly, it can still have further growth potential if its earnings increase at a commensurate rate. A good example of an earnings outperformer is Nvidia (NASDAQ: NVDA ). It saw its share price grow by triple digits last year. However, as its earnings grew at a similar rate, investors were comfortable continuing to push its share price higher in 2024. Analysts, CEOs and traders alike are reasonably focused on this key performance metric. The magnitude of earnings growth can predict how fast and to what extent a company’s share price may increase. However, identifying the top outperformers can be slightly more complex than simply picking stocks with the highest earnings. Some analysts worry that expectations for the coming earnings season are very high. It is useful to examine stocks with strong earnings growth that are projected to sustain it in the coming months.


Source:InvestorPlace